Baseline and overtime variations of soluble adhesion molecule plasma concentrations are associated with mobility recovery after rehabilitation in multiple sclerosis patients-Reference-Cited by-同舟云学术

Baseline and overtime variations of soluble adhesion molecule plasma concentrations are associated with mobility recovery after rehabilitation in multiple sclerosis patients

Published:2021-03 Issue: Volume:352 Page:577473
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Ziliotto Nicole,Lamberti Nicola,Manfredini Fabio,Straudi Sofia,Tisato Veronica,Carantoni Matteo,Melloni Elisabetta,Secchiero Paola,Basaglia Nino,Bernardi Francesco,Marchetti Giovanna

Funder

Regione Emilia-Romagna

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference66 articles.

1. Soluble vascular adhesion protein-1 correlates with cardiovascular risk factors and early atherosclerotic manifestations;Aalto;Arterioscler. Thromb. Vasc. Biol.,2012

2. Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis;Airas;J. Neuroimmunol.,2006

3. Response heterogeneity with exercise training and physical activity interventions among persons with multiple sclerosis;Baird;Neurorehabil. Neural Repair,2019

4. Issues and practices in multiple sclerosis;Burks;Neurorehabil. Neural Repair,2002

5. Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b;Calabresi;Ann. Neurol.,1997

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ICAM-1 may promote the loss of dopaminergic neurons by regulating inflammation in MPTP-induced Parkinson’s disease mouse models;Brain Research Bulletin;2024-08

2. Peripheral Immune Profiles Predict ALS Progression in an Age- and Sex-Dependent Manner;Neurology Neuroimmunology & Neuroinflammation;2024-05

3. Blood–brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies;The Lancet Neurology;2024-01

4. Use of Robotic Devices for Gait Training in Patients Diagnosed with Multiple Sclerosis: Current State of the Art;Sensors;2022-03-28

5. Combination of Genomic and Transcriptomic Approaches Highlights Vascular and Circadian Clock Components in Multiple Sclerosis;International Journal of Molecular Sciences;2021-12-28